Yahoo Malaysia Web Search

Search results

  1. Regeneron is a biotech company that develops new medicines for serious diseases, such as cancer, asthma and COVID-19. Learn about their scientific breakthroughs, clinical trials, responsibility goals and career opportunities.

    • Scientists

      Rapid response to infectious diseases. How can we go even...

    • Patients

      Compassionate use: Access to investigational medicines....

    • Medical Professionals

      Regeneron’s Compassionate Use Policy gives certain patients...

    • Investors and Media

      We are a leading science and technology company that...

    • Careers

      Working at Regeneron. We are a team of original thinkers who...

    • Find Trials

      Regeneron is a biotechnology company that develops medicines...

    • Improving Lives

      Regeneron has supported advocacy training, distribution of...

    • About

      At Regeneron, we move science to medicine because our world...

  2. Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.

  3. Regeneron is a leading biotechnology company using the power of science to bring new medicines to patients in need. Explore Regeneron's global presence.

  4. Regeneron is a biotech company that invents and develops medicines for serious diseases, such as eye, allergic, inflammatory, cancer, and rare diseases. Founded and led by physician-scientists, Regeneron uses proprietary technologies and genetics sequencing to create life-transforming treatments.

  5. Find the latest Regeneron Pharmaceuticals, Inc. (REGN) stock quote, history, news and other vital information to help you with your stock trading and investing.

  6. www.linkedin.com › company › regeneron-pharmaceuticalsRegeneron | LinkedIn

    Regeneron is a global biopharmaceutical company that invents, develops and commercializes life-transforming medicines for serious diseases. Follow its LinkedIn page to learn about its culture, science, careers and events.

  7. Regeneron is leading the way, developing new technologies to help discover better and novel antibody medicines. While most of our approved medicines are fully human monoclonal antibodies, we are exploring newer types of antibody medicines, including bispecific antibodies and antibody drug conjugates (ADCs).